High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin [3]

British Journal of Haematology

Volumn 129, Issue 5, 2005, Pages 709-710

  Magagnoli, Massimo ^a   Masci, Giovanna ^a   Castagna, Luca ^a   Bramanti, Stefania ^a   Morenghi, Emanuela ^a   Carnaghi, Carlo ^a   Santoro, Armande ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

5 fluorouracil; Cancer; Oxaliplatin; Warfarin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; RECOMBINANT THROMBOPLASTIN; WARFARIN;

ADULT; AGED; BLEEDING; CANCER; CANCER PATIENT; FEMALE; HEMOSTASIS; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; THROMBOCYTE COUNT; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; HEMOSTASIS; HUMANS; INCIDENCE; LEUCOVORIN; MALE; MIDDLE AGED; NEOPLASMS; ORGANOPLATINUM COMPOUNDS; PLATELET AGGREGATION INHIBITORS; WARFARIN;

EID: 20444460331     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05523.x     Document Type: Letter

References (5)

1. Andre, T., Boni, C, Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., Tabah-Fisch, I. & de Gramont, A. (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New England Journal of Medicine, 350, 2341-2351.
2. Bern, M.M., Lokich, J.J., Wallach, S.R., Bothe, Jr, A., Benotti, P.N., Arkin, C.F., Greco, F.A., Huberman, M. & Moore, C. (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Annals of Internal Medicine, 112, 423-428.
3. Doroshow, J.H., Synold, T.W., Gandara, D., Mani, S., Remick, S.C., Mulkerin, D., Hamilton, A., Sharma, S., Ramanathan, R.K., Lenz, H.J., Graham, M., Longmate, J., Takimoto, C.H. & Ivy, P. (2003) Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group. Seminars in Oncology, 30, 14-19.
4. Levine, M., Hirsh, J., Gent, M., Arnold, A., Warr, D., Falanga, A., Samosh, M., Bramwell, V., Pritchard, K.I. & Stewart, D. (1994) Double-blind randomized trial of very low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet, 343, 886-889.
5. Magagnoli, M., Masci, G., Carnaghi, C, Zucali, P.A., Castagna, L., Morenghi, E. & Santoro, A. (2003) Minidose warfarin is associated with high incidence of international normalized ratio (INR) elevation during chemotherapy with FOLFOX regimen. Annals of Oncology, 14, 959-960.